Our extensive experience in health technology assessment (HTA) through providing strategic advice and guiding evidence generation to support submissions to UK HTA bodies, enables us to provide you with a tailored solution to reimbursement and patient access.
EQ-5D-5L-derived utility drivers of HRQoL in HAE and comparison with patient-reported qualitative findings.